After backlash, Teva to resume supplies of critical children's cancer drug
At the time Teva halted production last July, there was no available alternative for vincristine, which is used to treat several childhood cancers.
Mary L. Brandt, MD
STAT Plus: After backlash, Teva will resume supplies of a critical children’s cancer medicine
. But the chaos described in the article seems avoidable.
& pharma, treat this as a sentinel event, learn the lessons it teaches, and design a better system.
After backlash, Teva will resume supplies of a critical children’s cancer medicine
will resume supplies of a critical children’s #cancer medicine #vincristine, by